Schematic overview of participant sampling timeline.
<p>(A) Individuals with a confirmed HIV-1 diagnosis started treatment during acute infection and were followed up in time. Blood sampling was performed at undetectable (UD; n = 9)) viral load (< 20 copies/mL) and again after 5 subsequent years (UD + 5; n = 5). (B) Individuals with a confirm...
Tallennettuna:
| Päätekijä: | |
|---|---|
| Muut tekijät: | , , , , , , , |
| Julkaistu: |
2025
|
| Aiheet: | |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|
| Yhteenveto: | <p>(A) Individuals with a confirmed HIV-1 diagnosis started treatment during acute infection and were followed up in time. Blood sampling was performed at undetectable (UD; n = 9)) viral load (< 20 copies/mL) and again after 5 subsequent years (UD + 5; n = 5). (B) Individuals with a confirmed HIV-1 diagnosis who began treatment during chronic infection, with blood sampling at undetectable viral load (UD; n = 10). (C) Individuals with a confirmed HIV-1 diagnosis who began treatment during chronic infection, with blood samples collected at varying durations on ART (UD + x, n = 57). Created in BioRender. Struyve, T. (2025) <a href="https://BioRender.com/cpljl4y" target="_blank">https://BioRender.com/cpljl4y</a>.</p> |
|---|